259 related articles for article (PubMed ID: 18989407)
21. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
[TBL] [Abstract][Full Text] [Related]
22. NKT-cell glycolipid agonist as adjuvant in synthetic vaccine.
Liu Z; Guo J
Carbohydr Res; 2017 Nov; 452():78-90. PubMed ID: 29080431
[TBL] [Abstract][Full Text] [Related]
23. Introduction of aromatic group on 4'-OH of α-GalCer manipulated NKT cell cytokine production.
Zhang W; Xia C; Nadas J; Chen W; Gu L; Wang PG
Bioorg Med Chem; 2011 Apr; 19(8):2767-76. PubMed ID: 21439833
[TBL] [Abstract][Full Text] [Related]
24. Identification of canine natural CD3-positive T cells expressing an invariant T-cell receptor alpha chain.
Yasuda N; Masuda K; Tsukui T; Teng A; Ishii Y
Vet Immunol Immunopathol; 2009 Dec; 132(2-4):224-31. PubMed ID: 19748683
[TBL] [Abstract][Full Text] [Related]
25. Lipid and glycolipid antigens of CD1d-restricted natural killer T cells.
Venkataswamy MM; Porcelli SA
Semin Immunol; 2010 Apr; 22(2):68-78. PubMed ID: 19945296
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms for glycolipid antigen-driven cytokine polarization by Valpha14i NKT cells.
Sullivan BA; Nagarajan NA; Wingender G; Wang J; Scott I; Tsuji M; Franck RW; Porcelli SA; Zajonc DM; Kronenberg M
J Immunol; 2010 Jan; 184(1):141-53. PubMed ID: 19949076
[TBL] [Abstract][Full Text] [Related]
27. Leishmania donovani glycosphingolipid facilitates antigen presentation by inducing relocation of CD1d into lipid rafts in infected macrophages.
Karmakar S; Paul J; De T
Eur J Immunol; 2011 May; 41(5):1376-87. PubMed ID: 21425159
[TBL] [Abstract][Full Text] [Related]
28. Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.
Webb TJ; Carey GB; East JE; Sun W; Bollino DR; Kimball AS; Brutkiewicz RR
Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27297969
[TBL] [Abstract][Full Text] [Related]
29. Mutation of a positively charged cytoplasmic motif within CD1d results in multiple defects in antigen presentation to NKT cells.
Shin JH; Park JY; Shin YH; Lee H; Park YK; Jung S; Park SH
J Immunol; 2012 Mar; 188(5):2235-43. PubMed ID: 22291186
[TBL] [Abstract][Full Text] [Related]
30. Structural evaluation of potent NKT cell agonists: implications for design of novel stimulatory ligands.
Schiefner A; Fujio M; Wu D; Wong CH; Wilson IA
J Mol Biol; 2009 Nov; 394(1):71-82. PubMed ID: 19732779
[TBL] [Abstract][Full Text] [Related]
31. Recognition of lysophosphatidylcholine by type II NKT cells and protection from an inflammatory liver disease.
Maricic I; Girardi E; Zajonc DM; Kumar V
J Immunol; 2014 Nov; 193(9):4580-9. PubMed ID: 25261475
[TBL] [Abstract][Full Text] [Related]
32. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.
Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM
J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659
[TBL] [Abstract][Full Text] [Related]
33. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.
Almeida CF; Smith DGM; Cheng TY; Harpur CM; Batleska E; Nguyen-Robertson CV; Nguyen T; Thelemann T; Reddiex SJJ; Li S; Eckle SBG; Van Rhijn I; Rossjohn J; Uldrich AP; Moody DB; Williams SJ; Pellicci DG; Godfrey DI
Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417291
[TBL] [Abstract][Full Text] [Related]
34. The natural killer T lymphocyte: a player in the complex regulation of autoimmune diabetes in non-obese diabetic mice.
Cardell SL
Clin Exp Immunol; 2006 Feb; 143(2):194-202. PubMed ID: 16412042
[TBL] [Abstract][Full Text] [Related]
35. Distinct CD1d docking strategies exhibited by diverse Type II NKT cell receptors.
Almeida CF; Sundararaj S; Le Nours J; Praveena T; Cao B; Burugupalli S; Smith DGM; Patel O; Brigl M; Pellicci DG; Williams SJ; Uldrich AP; Godfrey DI; Rossjohn J
Nat Commun; 2019 Nov; 10(1):5242. PubMed ID: 31748533
[TBL] [Abstract][Full Text] [Related]
36. Natural killer T cells within the liver: conductors of the hepatic immune orchestra.
Swain MG
Dig Dis; 2010; 28(1):7-13. PubMed ID: 20460885
[TBL] [Abstract][Full Text] [Related]
37. [NKT cells: their development, mechanisms and effects of action].
Bojarska-Junak A; Tabarkiewicz J; Roliński J
Postepy Hig Med Dosw (Online); 2013 Feb; 67():65-78. PubMed ID: 23475484
[TBL] [Abstract][Full Text] [Related]
38. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
[TBL] [Abstract][Full Text] [Related]
39. NKT cell-dependent regulation of secondary antigen-specific, conventional CD4+ T cell immune responses.
Shin Y; Hong C; Lee H; Shin JH; Hong S; Park SH
J Immunol; 2010 May; 184(10):5589-94. PubMed ID: 20375305
[TBL] [Abstract][Full Text] [Related]
40. [Sulfatide-loaded CD1d tetramer to detect typeII NKT cells in mice].
Zhang GQ; Nie HX; Yang J; Yu HY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jul; 28(7):696-8. PubMed ID: 22768857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
